Related Experiment Video
Updated: Jan 9, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
The 2024 National Diagnostic Reference Levels for Nuclear Medicine Imaging in Korea
Jahae Kim1, Soo Jin Kwon2, Myoung Hyoun Kim3
1Department of Nuclear Medicine, Chonnam National University Medical School and Hospital, 42 Jebong-ro, Dong-gu, Gwangju, 61469 Republic of Korea.
Purpose:
The Korean Society of Nuclear Medicine (KSNM) established the first diagnostic reference levels (DRLs) in Korea in 2019. Over the past five years, the need to update the DRLs has emerged for adult nuclear medicine imaging in Korea. The KSNM therefore conducted a nationwide survey and updated the DRLs for adult nuclear medicine examinations.
Methods:
A national DRL survey was conducted from March 2024 to April 2024 to investigate the administered activities of radiopharmaceuticals and the radiation doses from hybrid CT associated with PET/CT and SPECT/CT. Compared with the 2019 DRLs, the updated DRLs reflect newly approved radiopharmaceuticals in Korea, the introduction of SiPM-based PET/CT scanners, and expanded data on hybrid CT radiation exposure. The DRL survey team performed data collection and cleaning, while the DRL Task Force under the Radiation Safety Committee reviewed the draft. The 2024 DRLs were subsequently approved by the Radiation Safety Committee.
Results:
The current updated DRLs include 41 nuclear medicine imaging studies and nine hybrid CT studies. For PET radiopharmaceuticals, new DRLs were established for 18F-FDG in the purpose of myocardial viability assessment, infection/inflammation, and screening. Additionally, DRLs for 18F-Florbetaben, 18F-Flutemetamol and 18F-Florapronol for brain amyloid imaging were newly introduced. For SPECT radiopharmaceuticals, new DRLs were established for cardiac scintigraphy using 99mTc-DPD, HDP, or PYP, and for cardiac sympathetic nerve imaging with 123I-MIBG. The DRLs for hybrid CT doses (three PET/CT and six SPECT/CT studies) represent a novel addition in the 2024 nationwide survey. Furthermore, administered doses of radiopharmaceuticals and hybrid CT radiation doses were compared between conventional and SiPM-based PET/CT scanners.
Conclusions:
The DRLs for nuclear medicine imaging in Korean were updated. The 2024 DRLs will support the optimization of medical exposure to ionizing radiation in nuclear medicine imaging practice in Korea.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10:04Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Radiological Investigation I: X-ray and CT
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...